{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T06:43:49Z","timestamp":1694501029110},"reference-count":80,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T00:00:00Z","timestamp":1288742400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:bold>Purpose:<\/jats:bold> To enable clinicians to initiate appropriate steps for long\u2010term management of gout, including controlling acute exacerbations and pain and sustaining target serum uric acid (SUA) levels to control hyperuricemia as the underlying metabolic disorder.<\/jats:p><jats:p> <jats:bold>Data sources:<\/jats:bold> Incorporation of pertinent rheumatology and primary care literature seeking a comprehensive overview about the disease state of gout and its symptoms, comorbidities, and impact on quality of life, with a key focus on the role of serum uric acid, evidence\u2010based approaches to long\u2010term management of gout, and the importance of a functioning clinician\u2010patient relationship.<\/jats:p><jats:p> <jats:bold>Conclusions:<\/jats:bold> Gout is increasingly recognized as a prevalent chronic disease state requiring appropriate long\u2010term management while controlling for risk factors and comorbid conditions. Effective treatment options can help gout patients achieve therapeutic SUA targets to control gout flares and prevent potentially destructive disease manifestations. Patient education is an important element in achieving treatment goals and ensuring adherence.<\/jats:p><jats:p> <jats:bold>Implications for practice:<\/jats:bold> Effective treatment plans for any gout patient must be guided by a long\u2010term approach that focuses on sustained control of hyperuricemia, while providing continuous control of chronic disease. Patient education can be a key element in this process.<\/jats:p>","DOI":"10.1111\/j.1745-7599.2010.00556.x","type":"journal-article","created":{"date-parts":[[2010,11,7]],"date-time":"2010-11-07T04:32:25Z","timestamp":1289104345000},"page":"623-636","source":"Crossref","is-referenced-by-count":6,"title":["The current state of care in gout: Addressing the need for better understanding of an ancient disease"],"prefix":"10.1111","volume":"22","author":[{"given":"Michael E.","family":"Zychowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Graser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"e_1_2_29_2_1","first-page":"1923","article-title":"Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout","volume":"32","author":"Alvarez\u2010Nemegyei J.","year":"2005","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02188.x"},{"key":"e_1_2_29_4_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.071229"},{"key":"e_1_2_29_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2978"},{"key":"e_1_2_29_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20438"},{"key":"e_1_2_29_7_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.4.437"},{"key":"e_1_2_29_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"key":"e_1_2_29_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181896921"},{"key":"e_1_2_29_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328335ef38"},{"key":"e_1_2_29_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39449.819271.BE"},{"key":"e_1_2_29_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00270.x"},{"issue":"2","key":"e_1_2_29_13_1","first-page":"ii2\u2013ii8","article-title":"New insights into the epidemiology of gout","volume":"48","author":"Doherty M.","year":"2009","journal-title":"Rheumatology"},{"key":"e_1_2_29_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181896c35"},{"key":"e_1_2_29_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283257b96"},{"key":"e_1_2_29_16_1","first-page":"801","article-title":"Gout: An update","volume":"76","author":"Eggebeen A. T.","year":"2007","journal-title":"American Family Physician"},{"key":"e_1_2_29_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-75"},{"key":"e_1_2_29_18_1","first-page":"773","article-title":"Gout: Excess calories, purines, and alcohol intake and beyond. Response to a urate lowering diet","volume":"32","author":"Fam A. G.","year":"2005","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.07.035"},{"key":"e_1_2_29_20_1","first-page":"25","article-title":"Febuxostat: The evidence for its use in the treatment of hyperuricemia and gout","volume":"4","author":"Gaffo A. L.","year":"2009","journal-title":"Core Evidence"},{"key":"e_1_2_29_21_1","first-page":"2341","volume-title":"Arthritis and allied conditions","author":"Hahn P. C.","year":"2005"},{"key":"e_1_2_29_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945d2c"},{"key":"e_1_2_29_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2659"},{"key":"e_1_2_29_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.05.026"},{"key":"e_1_2_29_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1783"},{"key":"e_1_2_29_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283257b83"},{"key":"e_1_2_29_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7234.526"},{"key":"e_1_2_29_28_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2147\/TCRM.S3310","article-title":"Febuxostat in the management of hyperuricemia and chronic gout: A review","volume":"4","author":"Hu M.","year":"2008","journal-title":"Journal of Therapeutics and Clinical Risk Management"},{"key":"e_1_2_29_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.NHH.0000360924.64474.04"},{"key":"e_1_2_29_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181b562f8"},{"key":"e_1_2_29_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60799-0"},{"key":"e_1_2_29_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1457-8"},{"key":"e_1_2_29_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem056a"},{"key":"e_1_2_29_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.02.044"},{"key":"e_1_2_29_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-008-9355-0"},{"key":"e_1_2_29_36_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090034"},{"key":"e_1_2_29_37_1","doi-asserted-by":"crossref","first-page":"a485","DOI":"10.1136\/bmj.a485","article-title":"Interventions before consultations to help patients address their information needs by encouraging question asking: Systematic review","volume":"337","author":"Kinnersley P.","year":"2008","journal-title":"British Medical Journal"},{"key":"e_1_2_29_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33911"},{"key":"e_1_2_29_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-0248(81)90068-3"},{"key":"e_1_2_29_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep047"},{"key":"e_1_2_29_41_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-5-200109040-00027"},{"key":"e_1_2_29_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.11.696a"},{"key":"e_1_2_29_43_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.Suppl_5.S5"},{"key":"e_1_2_29_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3282f51031"},{"key":"e_1_2_29_45_1","first-page":"562","article-title":"Medication errors with the use of allopurinol and colchicine: A retrospective study of a national, anonymous internet\u2010accessible error reporting system","volume":"33","author":"Mikuls T. R.","year":"2006","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2008.01116.x"},{"key":"e_1_2_29_47_1","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"Neogi T.","year":"2006","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_48_1","volume-title":"Drinking water can reduce the risk of recurrent gout attacks","author":"Neogi T.","year":"2009"},{"key":"e_1_2_29_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340203"},{"key":"e_1_2_29_50_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-10-199911160-00007"},{"key":"e_1_2_29_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10511"},{"key":"e_1_2_29_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23007"},{"key":"e_1_2_29_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20221"},{"key":"e_1_2_29_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02107.x"},{"key":"e_1_2_29_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802136040"},{"key":"e_1_2_29_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091462"},{"key":"e_1_2_29_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0556"},{"key":"e_1_2_29_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000209882.50228.9f"},{"key":"e_1_2_29_59_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464210-00003"},{"key":"e_1_2_29_60_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560902950742"},{"key":"e_1_2_29_61_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.Suppl_5.S22"},{"key":"e_1_2_29_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken457"},{"key":"e_1_2_29_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20405"},{"key":"e_1_2_29_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.081604"},{"key":"e_1_2_29_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0022-4"},{"key":"e_1_2_29_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2509"},{"key":"e_1_2_29_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283369014"},{"key":"e_1_2_29_68_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666120-00002"},{"key":"e_1_2_29_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030733"},{"key":"e_1_2_29_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.08.006"},{"key":"e_1_2_29_71_1","volume-title":"New dosing guidelines for colchicine to avoid toxicity when used with Ca2+ channel blockers: The potent P\u2010Gp\/CYP3A4 inhibitor verapamil increases maximal concentration of single\u2010dose colchicine by 30% and exposure by \u223c100% in healthy subjects","author":"Terkeltaub R.","year":"2009"},{"key":"e_1_2_29_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2738"},{"key":"e_1_2_29_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.236"},{"key":"e_1_2_29_74_1","volume-title":"Ultrasonography shows active inflammation in clinically unaffected joints in chronic tophaceous gout","author":"Thiele R. G.","year":"2009"},{"key":"e_1_2_29_75_1","first-page":"1950","article-title":"The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis","volume":"29","author":"Urano W.","year":"2002","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_76_1","unstructured":"US Food and Drug Administration Web site. (2010). Retrieved June 8 2010 fromhttp:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/"},{"key":"e_1_2_29_77_1","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"Wallace K. L.","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_29_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000162060.25895.a5"},{"key":"e_1_2_29_79_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080487"},{"key":"e_1_2_29_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055251"},{"key":"e_1_2_29_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2010.00556.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2010.00556.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:15:50Z","timestamp":1694445350000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2010.00556.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":80,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1745-7599.2010.00556.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2010.00556.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}